Serotonin Syndrome Associated with Quetiapine

Clinical Presentation and Diagnosis

Serotonin syndrome typically presents with a triad of symptoms: mental status changes, neuromuscular hyperactivity, and autonomic instability, according to the American Academy of Pediatrics 2, 1
The most common clinical finding is myoclonus, occurring in approximately 57% of cases, as reported by the American Academy of Pediatrics 2
Clonus and hyperreflexia are considered highly diagnostic for serotonin syndrome when they occur in the setting of serotonergic drug use, as stated by the American Academy of Pediatrics 2
Symptoms usually develop within 24-48 hours after combining serotonergic medications or changing dosages, as noted by the Praxis Medical Insights 1
Hunter criteria are most commonly used for diagnosis of serotonin syndrome, according to the American Academy of Pediatrics 2

Severe cases of serotonin syndrome are characterized by hyperthermia (temperature >41.1°C), as reported by the American Academy of Pediatrics 2
Rhabdomyolysis with elevated creatine kinase is a complication of severe serotonin syndrome, as stated by the American Academy of Pediatrics 2
Metabolic acidosis is a complication of severe serotonin syndrome, according to the American Academy of Pediatrics 2
Elevated serum aminotransferase is a complication of severe serotonin syndrome, as reported by the American Academy of Pediatrics 2
Renal failure is a complication of severe serotonin syndrome, according to the American Academy of Pediatrics 2
Seizures are a complication of severe serotonin syndrome, as noted by the Praxis Medical Insights 1
Disseminated intravascular coagulopathy is a complication of severe serotonin syndrome, as reported by the American Academy of Pediatrics 2
The mortality rate is approximately 11%, indicating significant risk, according to the American Academy of Pediatrics 2

First-line treatment involves immediate discontinuation of all serotonergic agents, including quetiapine if it's suspected to be contributing, as recommended by the American Academy of Pediatrics and the Praxis Medical Insights 2, 1
Supportive care is essential, including benzodiazepines for agitation and tremor, as recommended by the American Academy of Pediatrics and the Praxis Medical Insights 2, 1
IV fluids for autonomic instability are part of supportive care, as recommended by the American Academy of Pediatrics and the Praxis Medical Insights 2, 1
External cooling for hyperthermia is part of supportive care, according to the American Academy of Pediatrics 2
Continuous cardiac monitoring is part of supportive care, as noted by the Praxis Medical Insights 1
Approximately 25% of patients require intubation, mechanical ventilation, and ICU admission, as reported by the American Academy of Pediatrics 2
Serotonin antagonists such as cyproheptadine may be considered, especially in severe cases, as recommended by the American Academy of Pediatrics and the Praxis Medical Insights 2, 1

Use caution when prescribing quetiapine alongside other serotonergic medications, particularly MAOIs, as noted by the Praxis Medical Insights 1
Use caution when prescribing quetiapine alongside opioids, particularly tramadol, meperidine, methadone, and fentanyl, as noted by the Praxis Medical Insights 1
Use caution when prescribing quetiapine alongside triptans, as reported by the American Academy of Pediatrics 2
Use caution when prescribing quetiapine alongside St. John's Wort, as noted by the Praxis Medical Insights 1
Start with low doses when adding a second serotonergic medication to an existing regimen, as recommended by the Praxis Medical Insights 1
Monitor closely for early signs of serotonin syndrome, especially during the first 24-48 hours after medication changes, as recommended by the Praxis Medical Insights 1
Consider patient-specific risk factors such as age, medication dosages, and concomitant use of CYP2D6 inhibitors, as noted by the Praxis Medical Insights 1